DK583188A - Farmaceutiske praeparater indeholdende ergolin-derivatet pergolid og fremgangsmaade til stabilisering af saadanne praeparater - Google Patents

Farmaceutiske praeparater indeholdende ergolin-derivatet pergolid og fremgangsmaade til stabilisering af saadanne praeparater

Info

Publication number
DK583188A
DK583188A DK583188A DK583188A DK583188A DK 583188 A DK583188 A DK 583188A DK 583188 A DK583188 A DK 583188A DK 583188 A DK583188 A DK 583188A DK 583188 A DK583188 A DK 583188A
Authority
DK
Denmark
Prior art keywords
preparations
stabilizing
pergolid
ergolin
derivative
Prior art date
Application number
DK583188A
Other languages
English (en)
Other versions
DK583188D0 (da
DK174831B1 (da
Inventor
James William Conine
Julian Larry Stowers
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK583188D0 publication Critical patent/DK583188D0/da
Publication of DK583188A publication Critical patent/DK583188A/da
Application granted granted Critical
Publication of DK174831B1 publication Critical patent/DK174831B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
DK198805831A 1987-10-26 1988-10-20 Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater DK174831B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/112,360 US4797405A (en) 1987-10-26 1987-10-26 Stabilized pergolide compositions
US11236087 1987-10-26

Publications (3)

Publication Number Publication Date
DK583188D0 DK583188D0 (da) 1988-10-20
DK583188A true DK583188A (da) 1989-04-27
DK174831B1 DK174831B1 (da) 2003-12-08

Family

ID=22343489

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805831A DK174831B1 (da) 1987-10-26 1988-10-20 Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater

Country Status (17)

Country Link
US (1) US4797405A (da)
EP (1) EP0314387B1 (da)
JP (1) JP2747303B2 (da)
KR (1) KR960013284B1 (da)
AT (1) ATE79258T1 (da)
AU (1) AU611494B2 (da)
CA (1) CA1318253C (da)
DE (1) DE3873688T2 (da)
DK (1) DK174831B1 (da)
ES (1) ES2042760T3 (da)
GR (1) GR3005784T3 (da)
HU (1) HU200691B (da)
IE (1) IE61960B1 (da)
IL (1) IL88087A (da)
NZ (1) NZ226650A (da)
PH (1) PH25575A (da)
ZA (1) ZA887805B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
JP4610834B2 (ja) * 1999-11-11 2011-01-12 杏林製薬株式会社 経口固形製剤
HUP0303355A3 (en) 2000-08-08 2005-06-28 Teva Pharma Stable pergolide mesylate and process for making same
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
AU2003215461A1 (en) * 2002-03-26 2003-10-08 Bernard Charles Sherman Stable tablets comprising pergolide mesylate
KR101302118B1 (ko) * 2011-04-22 2013-08-30 한림대학교 산학협력단 단백질 수송 도메인과 치료용 단백질이 공유결합한 융합 단백질에 퍼골라이드를 가하여 융합 단백질의 생체 세포 또는 조직 내 도입을 증가시키는 방법
US20190374534A1 (en) * 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) * 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US4473565A (en) * 1976-05-13 1984-09-25 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS5399316A (en) * 1977-02-04 1978-08-30 Sanpo Seiyaku Kk Stbilyzing method of leserpine preparation
AT362051B (de) * 1977-04-05 1981-04-27 Sandoz Ag Verfahren zur herstellung von injektions- praeparaten
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4329366A (en) * 1979-11-08 1982-05-11 Johnson & Johnson Products, Inc. Topical acylaminophenols
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
JPS58105913A (ja) * 1981-12-18 1983-06-24 Nippon Chemiphar Co Ltd ニフエジピン軟カプセル剤
JPS58206533A (ja) * 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンd↓3誘導体組成物及びそれを活性成分とする薬剤
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
JPS6176416A (ja) * 1984-09-20 1986-04-18 Fujimoto Seiyaku Kk 活性型ビタミンd↓3誘導体のカプセル剤用組成物
JPS6270317A (ja) * 1985-09-24 1987-03-31 Sawai Seiyaku Kk 活性型ビタミンd↓3類含有製剤
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten

Also Published As

Publication number Publication date
IE883199L (en) 1989-04-26
KR960013284B1 (ko) 1996-10-02
ZA887805B (en) 1990-06-27
IL88087A (en) 1992-09-06
IL88087A0 (en) 1989-06-30
KR890006238A (ko) 1989-06-12
JP2747303B2 (ja) 1998-05-06
IE61960B1 (en) 1994-11-30
HUT48462A (en) 1989-06-28
EP0314387B1 (en) 1992-08-12
PH25575A (en) 1991-08-08
CA1318253C (en) 1993-05-25
ATE79258T1 (de) 1992-08-15
NZ226650A (en) 1990-08-28
AU2408088A (en) 1989-04-27
DK583188D0 (da) 1988-10-20
HU200691B (en) 1990-08-28
US4797405A (en) 1989-01-10
GR3005784T3 (da) 1993-06-07
ES2042760T3 (es) 1993-12-16
DK174831B1 (da) 2003-12-08
AU611494B2 (en) 1991-06-13
JPH01146821A (ja) 1989-06-08
DE3873688T2 (de) 1993-03-11
EP0314387A1 (en) 1989-05-03
DE3873688D1 (de) 1992-09-17

Similar Documents

Publication Publication Date Title
DK583188D0 (da) Farmaceutiske praeparater indeholdende ergolin-derivatet pergolid og fremgangsmaade til stabilisering af saadanne praeparater
FI934274A (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
ATE269290T1 (de) Benzoylderivate
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
ES2084593T3 (es) La utilizacion de derivados de 4h-1-benzopiran-4-ona, nuevos derivados de 4h-1-benzopiran-4-ona y medicamentos que los contienen.
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
GB2080683B (en) Stabilization of pharmaceutical compositions containing acid addition salts of thieno-pyridine derivatives
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
DK156938C (da) Fremgangsmaade til fremstilling af et cephalosporinpraeparat
ES2043959T3 (es) Preparado farmaceutico estabilizado, que contiene n-acetilcisteina.
NO173635C (no) Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat
DE3853958D1 (de) Substituierte Pyridin-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
NO831951L (no) (+)-cyanidan-3-ol derivater, fremgangsmaater for deres fremstilling, farmasoeytiske preparater som inneholder slike forbindelser og deres anvendelse
DK305182A (da) Biologisk aktive heterobicycliske hydroximidater og thiolhydroximidater samt carbamatesterderivater deraf

Legal Events

Date Code Title Description
PUP Patent expired